Search
for
Sort by
Research 91–120 of 1000+
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Janus kinase inhibitors in dermatology: A systematic review
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Janus Kinase inhibitors in dermatology: a review
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Psychophysiological Mechanisms of Stress Impact on Hair Loss Processes
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- New drugs under investigation for the treatment of alopecias
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata